--- source_url: https://hangovr180.com/science/dhm/gaba-modulation.md canonical_url: https://hangovr180.com/science/dhm/gaba-modulation generated_at: 2026-06-28T19:53:17Z build_id: ebfcfef page_type: science-leaf claim_ids: [SF-29, SF-31, SF-25] --- # DHM AND GABA MODULATION *Alcohol hijacks the GABA-A receptor to dial down your anxiety while you drink, then your nervous system rebounds the next morning, and DHM gets in the middle of that loop without sedating you.* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. ## The Other Half of the DHM Story Most of the DHM research falls into two camps. One camp is about liver enzymes and how DHM helps your body clear ethanol and acetaldehyde. The other camp is about the brain, specifically about the GABA-A receptor and how DHM behaves there. The brain side is what explains anxiety, sleep quality, and the next-day mood crash that often comes after drinking. GABA is the main inhibitory neurotransmitter in your brain. When GABA binds to its receptor, neurons quiet down. Alcohol enhances that effect, which is part of why drinks make people feel relaxed in the first hour. Over time though, the receptor adapts -- it becomes less responsive, the body compensates, and when alcohol clears, you are left with too little inhibition and a rebound spike of anxiety[1]. ## What DHM Does at the Receptor DHM is a positive modulator of the GABA-A receptor at the benzodiazepine binding site. That puts it in the same general family as drugs like diazepam, with one critical difference: at the doses that block alcohol's effects on the receptor, DHM does not sedate, does not cause sleep, and does not produce tolerance[1]. That confused me when I first read it. I had expected anything that touches the GABA-A site to make people drowsy by default. > **Claim [SF-29]:** Product promotes calm mood and relief from occasional anxiety by blocking alcohol-induced activation of GABA. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The original Shen 2012 paper from UCLA showed that DHM counteracts ethanol-induced GABA-A potentiation in rat brain tissue, blocks acute alcohol intoxication, prevents tolerance development, and reduces withdrawal-related anxiety and seizure susceptibility[1]. That is a long list of effects from a single flavonoid, and it confused researchers when the paper first dropped because the pharmacological profile didn't match anything else on the shelf. ## The Hippocampus and Gephyrin A 2020 follow-up study looked specifically at DHM's effect inside the hippocampus. The researchers found that DHM modulation of GABAergic transmission in this region improved anxiety behavior in mice and restored levels of gephyrin, a scaffolding protein that anchors GABA-A receptors at the synapse and that gets disrupted by chronic alcohol exposure[2]. > **Claim [SF-31]:** Provides relief from occasional anxiety from moderate alcohol use. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. In plainer English: chronic alcohol degrades the physical infrastructure that holds GABA receptors in place, and DHM appears to help that infrastructure stay put. (this was the part that personally surprised me, because I had assumed the GABA effect was purely about receptor binding rather than structural protein levels.) ## Why This Matters for the Day After The morning-after anxiety that comes with even moderate drinking is largely a GABA story. As alcohol clears, the brain is left with a temporarily down-regulated inhibitory system and a temporarily up-regulated excitatory one. The result is the jittery, edge-of-panic feeling that some people get even after one or two drinks the night before[3]. > **Claim [SF-25]:** Product promotes calm mood and relief from occasional anxiety by blocking activation of GABA. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. DHM's profile, in the published animal data at least, suggests it blunts both ends of that swing. It limits how dramatically alcohol pushes the receptor in the first place, which means there is less of a rebound to recover from. It also does not produce the tolerance that benzodiazepines do, which is why this approach is structurally different from "just take a benzo before bed"[4]. ## What the Brain Concentrations Look Like A 2021 mass-spec study identified intact DHM and its primary metabolites in mouse brain tissue after oral dosing, with kinetics consistent with the behavioral effects researchers had been measuring for years[5]. That matters because a lot of flavonoids never cross the blood-brain barrier in usable amounts. DHM does, which is one reason the GABA-A effects in animals translate at all. ## What This Page Is Not Claiming DHM is not a treatment for anxiety disorders. It is not a substitute for medical care, and the research that exists is mostly in animals, with the human clinical literature on DHM specifically for anxiety still thin. What the research does suggest is that the GABA mechanism is real, the alcohol-blocking effect is reproducible across labs, and the absence of sedation makes DHM unusual among compounds taht touch this receptor system. For the metabolic side of DHM -- how it helps your liver clear ethanol and acetaldehyde -- see [How DHM Works: The ADH/ALDH Pathway](/science/dhm/adh-aldh-pathway). For the dose math behind why we use 1,500mg per serving, see [DHM Dose-Response](/science/dhm/dose-response). ## Citations 1. Shen Y, et al. [Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication](https://pmc.ncbi.nlm.nih.gov/articles/PMC3292407/). PMC3292407. 2. Liang J, et al. [Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety](https://pmc.ncbi.nlm.nih.gov/articles/PMC7364153/). PMC7364153. 3. Olsen RW, Liang J. [GABAergic Signaling in Alcohol Use Disorder and Withdrawal -- Pathological Involvement and Therapeutic Potential](https://pmc.ncbi.nlm.nih.gov/articles/PMC10623140/). PMC10623140. 4. Davies M. [Alcohol Use Disorders and Current Pharmacological Therapies -- The Role of GABA-A Receptors](https://pmc.ncbi.nlm.nih.gov/articles/PMC4125717/). PMC4125717. 5. Silva J, et al. [Identification of Dihydromyricetin and Metabolites in Serum and Brain Associated with Acute Anti-Ethanol Intoxicating Effects in Mice](https://pmc.ncbi.nlm.nih.gov/articles/PMC8307506/). PMC8307506. ## Read Next - [How DHM Works -- The ADH/ALDH Pathway](/science/dhm/adh-aldh-pathway) - [DHM Dose-Response -- Why 1,500mg](/science/dhm/dose-response) - [DHM and Brain Aging](/science/dhm/brain-aging) - [DHM -- The Hub](/science/dhm) **Written by Mark Scott** - Co-Formulator, Hangovr180® | Co-Inventor, [US Application 18/698,010](https://patents.google.com/patent/US20250073201A1) Mark Scott conducted approximately 150 personal formulation tests over six months to develop the H180 ingredient combination. [Editorial standards](/editorial-standards) --- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Hangovr180® is a dietary supplement. Individual results may vary. Consult your healthcare provider before use if you have any medical conditions or take medications. [US Application 18/698,010](https://patents.google.com/patent/US20250073201A1). Canonical: https://hangovr180.com/science/dhm/gaba-modulation